Reporting immunoglobulin gene analysis in CLL: updates to the ERIC guidelines
Anastasia Chatzidimitriou, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses updates to the European Research Initiative on CLL (ERIC) recommendations on how to report the results from immunoglobulin heavy variable gene analysis in chronic lymphocytic leukemia (CLL). This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
